These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Characterization of the insulin-antagonistic effect of growth hormone in man. Fowelin J; Attvall S; von Schenck H; Smith U; Lager I Diabetologia; 1991 Jul; 34(7):500-6. PubMed ID: 1916055 [TBL] [Abstract][Full Text] [Related]
5. Simple empirical assessment of beta-cell function by a constant infusion of glucose test in normal and type 2 (non-insulin-dependent) diabetic subjects. Levy JC; Rudenski A; Burnett M; Knight R; Matthews DR; Turner RC Diabetologia; 1991 Jul; 34(7):488-99. PubMed ID: 1916054 [TBL] [Abstract][Full Text] [Related]
6. ACE-inhibition increases hepatic and extrahepatic sensitivity to insulin in patients with type 2 (non-insulin-dependent) diabetes mellitus and arterial hypertension. Torlone E; Rambotti AM; Perriello G; Botta G; Santeusanio F; Brunetti P; Bolli GB Diabetologia; 1991 Feb; 34(2):119-25. PubMed ID: 2065846 [TBL] [Abstract][Full Text] [Related]
8. Glucose-mediated glucose disposal in insulin-resistant normoglycemic relatives of type 2 diabetic patients. Henriksen JE; Levin K; Thye-Rønn P; Alford F; Hother-Nielsen O; Holst JJ; Beck-Nielsen H Diabetes; 2000 Jul; 49(7):1209-18. PubMed ID: 10909980 [TBL] [Abstract][Full Text] [Related]
9. The 'dawn phenomenon' in adolescents with insulin dependent diabetes mellitus: possible contribution of insulin-like growth factor binding protein-1. Cotterill AM; Daly F; Holly JM; Hughes SC; Camacho-Hübner C; Abdulla AF; Gale EA; Savage MO Clin Endocrinol (Oxf); 1995 Nov; 43(5):567-74. PubMed ID: 8548941 [TBL] [Abstract][Full Text] [Related]
10. Suppression of insulin secretion by falling plasma glucose levels is impaired in type 2 diabetes. Hosker JP; Burnett MA; Matthews DR; Turner RC Diabet Med; 1988 Dec; 5(9):856-60. PubMed ID: 2976647 [TBL] [Abstract][Full Text] [Related]
11. Glucose turnover and recycling in diabetes secondary to total pancreatectomy: effect of glucagon infusion. Vigili de Kreutzenberg S; Maifreni L; Lisato G; Riccio A; Trevisan R; Tiengo A; Del Prato S J Clin Endocrinol Metab; 1990 Apr; 70(4):1023-9. PubMed ID: 2180971 [TBL] [Abstract][Full Text] [Related]
12. [Effect of insulin on glucose and and fat metabolism in ewes during various reproductive states in normal and hypocalcemia]. Schlumbohm C; Sporleder HP; Gürtler H; Harmeyer J Dtsch Tierarztl Wochenschr; 1997 Sep; 104(9):359-65. PubMed ID: 9410723 [TBL] [Abstract][Full Text] [Related]
13. Mechanism of metformin action in obese and lean noninsulin-dependent diabetic subjects. DeFronzo RA; Barzilai N; Simonson DC J Clin Endocrinol Metab; 1991 Dec; 73(6):1294-301. PubMed ID: 1955512 [TBL] [Abstract][Full Text] [Related]
14. Influence of continuous physiologic hyperinsulinemia on glucose kinetics and counterregulatory hormones in normal and diabetic humans. Saccà L; Sherwin R; Hendler R; Felig P J Clin Invest; 1979 May; 63(5):849-57. PubMed ID: 447832 [TBL] [Abstract][Full Text] [Related]
15. Insulin-mediated glucose disposal in type I diabetes: evidence for insulin resistance. Del Prato S; Nosadini R; Tiengo A; Tessari P; Avogaro A; Trevisan R; Valerio A; Muggeo M; Cobelli C; Toffolo G J Clin Endocrinol Metab; 1983 Nov; 57(5):904-10. PubMed ID: 6352727 [TBL] [Abstract][Full Text] [Related]
16. Glucose disposal and intermediary metabolism during one year of continuous subcutaneous insulin infusion (CSII). Nijs HG; Radder JK; Poorthuis BJ; Krans HM Diabetes Res Clin Pract; 1991 Apr; 12(1):1-9. PubMed ID: 1855435 [TBL] [Abstract][Full Text] [Related]
17. Improved in vivo insulin effect during continuous subcutaneous insulin infusion in patients with IDDM. Beck-Nielsen H; Richelsen B; Hasling C; Nielsen OH; Heding L; Sørensen NS Diabetes; 1984 Sep; 33(9):832-7. PubMed ID: 6381179 [TBL] [Abstract][Full Text] [Related]
19. Improved postprandial metabolic control after subcutaneous injection of a short-acting insulin analog in IDDM of short duration with residual pancreatic beta-cell function. Pampanelli S; Torlone E; Ialli C; Del Sindaco P; Ciofetta M; Lepore M; Bartocci L; Brunetti P; Bolli GB Diabetes Care; 1995 Nov; 18(11):1452-9. PubMed ID: 8722069 [TBL] [Abstract][Full Text] [Related]
20. Occurrence of dawn phenomenon without change in insulin clearance in patients with insulin-dependent diabetes mellitus. Campbell PJ; Gerich JE Diabetes; 1986 Jul; 35(7):749-52. PubMed ID: 3522315 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]